Affiliation:
1. Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine, Cangzhou, China
2. Department of Traditional Chinese Medicine Surgery, Hebei University of Chinese Medicine, Shijiazhuang, China
3. Traditional Chinese Medicine Hospital of Jiaozuo City, Henan Province, Jiaozuo, China
Abstract
Objective. To explore the mechanism of the action of Huoluo Xiaoling Dan (HLXLD) in the treatment of psoriasis based on network pharmacology and molecular docking. Methods. The main active components and targets of HLXLD were collected from CMSP, and the targets related to psoriasis were collected from GeneCards, OMIM, TTD, DisGeNET, and DrugBank. Drug disease target genes were obtained by Venny tools, drug-component-target networks were constructed and analyzed, and pathway enrichment analysis was performed. AutoDockTools is used to connect the core components and the target, and PyMOL software is used to visualize the results. Results. 126 active components (such as quercetin, luteolin, tanshinone IIA, dihydrotanshinlactone, and beta-sitosterol) and 238 targets of HLXLD were screened out. 1,293 targets of psoriasis were obtained, and 123 drug-disease targets were identified. Key targets included AKT1, TNF, IL6, TP53, VEGFA, JUN, CASP3, IL1B, STAT3, PTGS2, HIF1A, EGF, MYC, EGFR, MMP9, and PPARG. Enrichment analysis showed that 735 GO analysis and 85 KEGG pathways were mainly involved in biological processes such as response to the drug, inflammatory response, gene expression, and cell proliferation and apoptosis, as well as signal pathways such as cancer, TNF, HIF-1, and T cell receptor. Molecular docking showed that there was strong binding activity between the active ingredient and the target protein. Conclusions. HLXLD could treat psoriasis through multicomponents, multitargets, and multipathways, which provides a new theoretical basis for further basic research and clinical application.
Funder
Scientific Research Project of Hebei Administration of Traditional Chinese Medicine
Subject
Complementary and alternative medicine
Reference64 articles.
1. Analysis of the epidemiological burden of psoriasis in China based on the big data of global burden of disease study(GBD);H. Li;The Chinese Journal of Dermatovenereology,2021
2. Histologic comparison of tumor necrosis factor-α inhibitor–induced psoriasis and psoriasis vulgaris
3. Modern literature study on syndrome distribution and Chinese medicine medication regularity in treatment of psoriasis vulgaris;Y. Cao;Journal of Guangzhou University of Traditional Chinese Medicine,2020
4. Discussion on the treatment of plaque psoriasis with fire acupuncture combined with cotton moxibustion based on collateral disease theory;Y. Ji;Journal of Liaoning University of Traditional Chinese Medicine,2022
5. Clinical observation on Treating 30 cases of psoriasis vulgaris from collateral disease;J. Guo;Guiding Journal of Traditional Chinese Medicine and Pharmacy,2012